|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Interstitial Cystitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cystitis | |||||
| Cystitis, Interstitial | |||||
| 3 | More general conditions related to this trial | ||||
| Urinary Bladder Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| pentosan polysulfate sodium | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Pentosan Sulfuric Polyester | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anticoagulants | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| McNeil Consumer &Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | |||||